UNICA IRIS Institutional Research Information System

DEVOTO, PAOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 150.939
NA - Nord America 9.154
AS - Asia 3.748
SA - Sud America 528
AF - Africa 74
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 3
Totale 164.450
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 147.415
US - Stati Uniti d'America 9.040
SG - Singapore 1.485
CN - Cina 1.377
NL - Olanda 1.089
UA - Ucraina 637
SE - Svezia 609
BR - Brasile 416
DE - Germania 322
VN - Vietnam 263
FI - Finlandia 261
GB - Regno Unito 259
FR - Francia 195
HK - Hong Kong 111
IN - India 104
KR - Corea 102
CA - Canada 55
BD - Bangladesh 37
AR - Argentina 36
JP - Giappone 36
IQ - Iraq 34
MX - Messico 34
RU - Federazione Russa 29
TR - Turchia 27
ZA - Sudafrica 27
CO - Colombia 26
PK - Pakistan 23
PL - Polonia 22
UZ - Uzbekistan 19
BE - Belgio 18
EC - Ecuador 18
ES - Italia 16
MA - Marocco 16
CZ - Repubblica Ceca 14
ID - Indonesia 14
IR - Iran 14
PH - Filippine 13
VE - Venezuela 10
AZ - Azerbaigian 9
AT - Austria 8
MY - Malesia 8
PS - Palestinian Territory 8
AE - Emirati Arabi Uniti 7
IE - Irlanda 7
JM - Giamaica 7
KE - Kenya 7
CL - Cile 6
CR - Costa Rica 6
JO - Giordania 6
MU - Mauritius 6
SA - Arabia Saudita 6
DZ - Algeria 5
LB - Libano 5
PE - Perù 5
PT - Portogallo 5
PY - Paraguay 5
BG - Bulgaria 4
BY - Bielorussia 4
CH - Svizzera 4
EU - Europa 4
IL - Israele 4
KG - Kirghizistan 4
KZ - Kazakistan 4
PA - Panama 4
UY - Uruguay 4
AM - Armenia 3
HU - Ungheria 3
LK - Sri Lanka 3
LT - Lituania 3
NP - Nepal 3
TH - Thailandia 3
TN - Tunisia 3
AL - Albania 2
AU - Australia 2
BN - Brunei Darussalam 2
BO - Bolivia 2
EG - Egitto 2
HN - Honduras 2
KW - Kuwait 2
MD - Moldavia 2
OM - Oman 2
QA - Qatar 2
RO - Romania 2
SN - Senegal 2
TW - Taiwan 2
AO - Angola 1
BB - Barbados 1
BW - Botswana 1
CG - Congo 1
CI - Costa d'Avorio 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EE - Estonia 1
FJ - Figi 1
GE - Georgia 1
GH - Ghana 1
GR - Grecia 1
GT - Guatemala 1
HR - Croazia 1
KH - Cambogia 1
Totale 164.437
Salva come PNG Salva come JPEG
Città #
Cagliari 142.995
Uta 3.986
Amsterdam 1.068
Fairfield 898
Ashburn 819
Woodbridge 713
Singapore 711
Chandler 609
Houston 552
San Jose 519
Ann Arbor 418
Seattle 370
Boardman 338
Jacksonville 337
Dallas 332
Nyköping 331
Wilmington 321
Dearborn 291
Cambridge 280
Beijing 230
Helsinki 160
Los Angeles 159
Hefei 130
The Dalles 125
Nanjing 114
Lauterbourg 103
Hong Kong 101
Santa Clara 97
Shanghai 93
Seoul 92
Boston 91
Council Bluffs 91
Ho Chi Minh City 88
San Diego 81
Hanoi 61
Buffalo 58
New York 53
Shenyang 50
Munich 45
Milan 44
Guangzhou 39
Nanchang 37
São Paulo 34
Hebei 32
London 32
Frankfurt am Main 31
Redwood City 30
Tianjin 29
Orem 26
Washington 26
Redondo Beach 25
Changsha 23
Chicago 23
Tokyo 23
Dong Ket 22
Verona 22
Brooklyn 20
Johannesburg 20
Santa Maria Coghínas 20
Kunming 19
Brussels 18
Mountain View 18
Norwalk 18
Pune 18
San Francisco 18
San Mateo 18
Toronto 18
Zhengzhou 18
Orange 17
Tashkent 17
Jiaxing 16
Jinan 16
Mumbai 16
Chennai 15
Montreal 15
Rio de Janeiro 15
Rome 15
Atlanta 14
Detroit 14
Ningbo 13
Warsaw 13
Leawood 12
Phoenix 12
Augusta 11
Da Nang 11
Falls Church 11
Auburn Hills 10
Baghdad 10
Brasília 10
Brno 10
Denver 10
Manchester 10
Shenzhen 10
Bogotá 9
Casablanca 9
Monmouth Junction 9
Stockholm 9
Ankara 8
Baku 8
Quito 8
Totale 159.014
Salva come PNG Salva come JPEG
Nome #
5alpha-reductase inhibitors dampen L-DOPA-induced dyskinesia via normalization of dopamine D1-receptor signaling pathway and D1-D3 receptor interaction 5.827
Maternal immune activation disrupts dopamine system in the offspring 4.152
The 5-alpha reductase inhibitor finasteride reduces dyskinesia in a rat model of Parkinson's disease 4.082
The neurosteroidogenic enzyme 5α-reductase mediates psychotic-like complications of sleep deprivation 3.707
Selective inhibition of dopamine-beta-hydroxylase enhances dopamine release from noradrenergic terminals in the medial prefrontal cortex 3.510
The neurosteroidogenic enzyme 5α-reductase modulates the role of D1 dopamine receptors in rat sensorimotor gating 3.277
Elevated dopamine in the medial prefrontal cortex suppresses cocaine seeking via D1 receptor overstimulation 3.036
Gene-environment interactions in antisocial behavior are mediated by early-life 5-HT2A receptor activation 3.028
null 2.940
Selective activation of D1 dopamine receptors impairs sensorimotor gating in Long-Evans rats 2.891
Noradrenergic terminals are the primary source of α2-adrenoceptor mediated dopamine release in the medial prefrontal cortex 2.873
Inhibition of 17α-hydroxylase/C17,20 lyase reduces gating deficits consequent to dopaminergic activation 2.786
Targeting neurosteroid synthesis as a therapy for schizophrenia-related alterations induced by early psychosocial stress 2.735
The PPARα agonist fenofibrate attenuates disruption of dopamine function in a maternal immune activation rat model of schizophrenia 2.723
Inhibition of steroid 5-alpha reductase reduces marble-burying responses in mice 2.705
NMDARs mediate the role of monoamine oxidase A in pathological aggression 2.620
Inhibition of 5 alpha-reductase in the nucleus accumbens counters sensorimotor gating deficits induced by dopaminergic activation 2.609
Positive allosteric modulation of GABAB receptors ameliorates sensorimotor gating in rodent models 2.607
Allopregnanolone mediates manic-like outcomes of REM sleep deprivation 2.526
Effects of maternal immune activation on dopamine activity in male and female offspring 2.460
Levodopa prevents the reinstatement of cocaine self-administration in rats via potentiation of dopamine release in the medial prefrontal cortex 2.432
Startle Reflex as a possible biomarker associated with REM sleep behavior disorders in the prodromal stage of Parkinson's disease 2.347
Blockade of 5-alpha reductase reduces compulsive behaviors in mice 2.316
Inhibition of 5α-reductase attenuates behavioral effects of D1-, but not D2-like receptor agonists in C57BL/6 mice 2.285
Allopregnanolone mediates manic-like outcomes of REM sleep deprivation 2.278
Noradrenaline neuron degeneration contributes to motor impairments and development of L-DOPA-induced dyskinesia in a rat model of Parkinson's disease 2.270
Modulation of the Startle Response in REM Sleep Behavior Disorder 2.263
Juvenile cannabinoid treatment induces frontostriatal gliogenesis in Lewis rats 2.154
NMDA receptors mediate the role of monoamine oxidase A in pathological aggression 2.077
Disulfiram stimulates dopamine release from noradrenergic terminals and potentiates cocaine-induced dopamine release in the prefrontal cortex 2.053
The steroid 5-alpha reductases mediate the abnormalities in information processing and attention mechanisms induced by REM sleep deprivation 2.023
The levels of the NMDA receptor co-agonist D-serine are reduced in the substantia nigra of MPTP-lesioned macaques and in the cerebrospinal fluid of Parkinson’s disease patients 2.020
6-Hydroxydopamine lesion in the ventral tegmental area fails to reduce extracellular dopamine in the cerebral cortex 1.937
null 1.934
Antipsychotic-like properties of antiandrogenic drugs: focus on dopaminergic system 1.875
The implication of neuroactive steroids in tourette's syndrome pathogenesis: A role for 5α-reductase? 1.862
Reserpine treatment ablates the deficits of sensorimotor gating induced by dopamine D3 receptor activation in Sprague-Dawley, but not Long-Evans rats 1.847
Inhibition of 5-alpha reductase elicits antipsychotic-like effects via post-synaptic mechyanisms in nucleus accumbens and prefrontal cortex 1.826
Co-release of noradrenaline and dopamine in the cerebral cortex elicited by single train and repeated train stimulation of the locus coeruleus 1.819
Prenatal THC exposure produces a hyperdopaminergic phenotype rescued by pregnenolone 1.767
null 1.722
5-alpha reductase expression is reduced in brain of isolation-reared rats: relevance to dopaminergic impairments 1.710
Inhibition of 5α-reductase counters the behavioral effects of D1, but not D2 dopamine receptor activation 1.634
Noradrenergic Source of Dopamine Assessed by Microdialysis in the Medial Prefrontal Cortex 1.631
Isolation rearing-induced reduction of brain 5 alpha-reductase expression: Relevance to dopaminergic impairments 1.625
Pramipexole enhances disadvantageous decision-making: Lack of relation to changes in phasic dopamine release 1.601
Alpha2-adrenoceptor mediated co-release of dopamine and noradrenaline from noradrenergic neurons in the cerebral cortex 1.600
Fasting biases µ-opioid receptors toward β–arrestin2-dependent signaling in the accumbens shell 1.534
Exploring the neural mechanisms of finasteride: a proteomic analysis in the nucleus accumbens 1.493
Midbrain 6-OHDA lesion fails to reduce extracellular dopamine in cerebral cortex. 1.481
Inhibition of 5-alpha reductase elicits antipsychotic-like effects via post-synaptic mechanisms in nucleus accumbens and prefrontal cortex 1.464
Stimulation of the locus coeruleus elicits noradrenaline and dopamine release in the medial prefrontal and parietal cortex 1.455
Mirtazapine-induced corelease of dopamine and noradrenaline from noradrenergic neurons in the medial prefrontal and occipital cortex 1.385
The genetic deletion of monoamine oxidase (MAO) gene promotes autistic-like phenotypes in mice 1.365
Role of Dopamine D2/D3 Receptors in Development, Plasticity, and Neuroprotection in Human iPSC-Derived Midbrain Dopaminergic Neurons 1.365
Dopamine-beta-hydroxylase inhibition potentiates cocaine effect on dopamine release in the medial prefrontal cortex 1.343
Origin of extracellular dopamine from dopamine and noradrenaline neurons in the medial prefrontal and occipital cortex 1.332
The control of responsiveness in ADHD by catecholamines: evidence for dopaminergic, noradrenergic and interactive roles 1.317
Effects of post-weaning social isolation on 5-alpha reductase: Relevance to dopaminergic pathway 1.317
Altered expression level of nucleus accumbens proteins in isolation-reared rats 1.298
EFFECT OF NORADRENERGIC DENERVATION ON CEREBRAL CORTEX CATECHOLAMINES IN THE RAT 1.281
Early postnatal inhibition of serotonin synthesis results in long-term reductions of perseverative behaviors, but not aggression, in MAO A-deficient mice 1.165
Steroid 5 alpha-reductase as a novel therapeutic target for schizophrenia and other neuropsychiatric disorders 1.100
null 1.078
Thymic oxytocin like immunoreactivity is increased in morphine tolerant dependent rats 1.006
Lead intoxication during intrauterine life and lactation but not during adulthood reduces nucleus accumbens dopamine release as studied by brain microdialysis 928
Dissociation of haloperidol, clozapine, and olanzapine effects on electrical activity of mesocortical dopamine neurons and dopamine release in the prefrontal cortex 918
5-alpha reductase inhibitors as a novel therapy for Tourette Syndrome: Clinical Evidence 836
Detection of 3H-cimetidine specific binding in rat anterior pituitary 773
5-Alpha reductase inhibitors modulate dopaminergic signaling: relevance to psychosis 772
Biochemical and electrophysiological effects of 7-OH-DPAT on the mesolimbic dopaminergic system 713
Disulfiram and diethylditiocarbamate intoxication affects the storage and release of striatal dopamine 654
Impaired dopamine D3 and nicotinic acetylcholine receptor membrane localization in iPSCs-derived dopaminergic neurons from two Parkinson’s disease patients carrying the LRRK2 G2019S mutation 646
Biochemical characterization of rat forebrain septum dopaminergic innervation. 631
The potent α2-adrenoceptor antagonist RS 79948 also inhibits dopamine D2 -receptors: Comparison with atipamezole and raclopride 623
Central dopaminergic transmission is selectively increased in the limbic system of rats chronically exposed to antidepressants 619
Chronic SCH 23390 produces tolerance to morphine extrapiramidal effects 597
Prenatal THC Does Not Affect Female Mesolimbic Dopaminergic System in Preadolescent Rats 532
Decreased adenosine A2 receptor function in morphine dependent rats 531
Chronic imipramine reduces [3H]SCH 23390 binding and DA sensitive adenylate cyclase in the limbic system 524
Evidence that cortical dopamine is a co-transmitter in noradrenergic neurons 512
Selective adenylate cyclase increase in the limbic area of long term imipramine treated rats 511
Resistance to extrapyramidal effects of opiates in rats chronically treated with SCH 23390 509
Effect of calcium antagonists on [3H] dopamine uptake 508
Delta(9)-tetrahydrocannabinol decreases extracellular GABA and increases extracellular glutamate and dopamine levels in the rat prefrontal cortex: an in vivo microdialysis study 481
null 470
On the origin of cortical dopamine: Is it a co-transmitter in noradrenergic neurons? 468
The dopamine beta-hydroxylase inhibitor nepicastat increases dopamine release and potentiates psychostimulant-induced dopamine release in the prefrontal cortex 452
Opioid activity of lefetamine 446
Labetalol blockade of central alpha- and beta-noradrenergic receptors in rat brain homogenates 435
Gating deficits in isolation-reared rats are correlated with alterations in protein expression in nucleus accumbens 412
[3H] spiroperidol binding to a putative dopaminergic receptor in rat pituitary gland 411
Co-release of dopamine and noradrenaline from noradrenergic neurons in the cerebral cortex: implication for the neurobiology of psychiatric disorders 410
Differential effect of Mu, Delta, and kappa opioid agonists on adenylate cyclase activity 404
Possible antidepressant activity of methadone 404
Adrenergic sensitive adenylate cyclase in rat posterior pituitary 400
Behavioural sensitization of mesolimbic dopamine D2 receptors in chronic fluoxetine-treated rats 396
Opiate k receptors agonists do not inhibit adenylate cyclase activity 395
In utero exposure to methadone produces a stable decrease of the cortex 5-HT transport system in rats 386
null 381
Totale 158.869
Salva come PNG Salva come JPEG
Categoria #
all - tutte 210.971
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 210.971
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.581 0 0 0 0 0 0 0 0 0 0 0 1.581
2021/20228.438 914 581 730 497 582 688 581 540 606 765 906 1.048
2022/202311.351 1.061 1.414 1.128 937 979 1.159 642 802 882 784 1.023 540
2023/202411.816 618 497 457 644 1.117 1.613 1.785 726 744 878 1.219 1.518
2024/202519.556 3.819 4.439 3.814 1.927 1.008 1.065 1.208 172 321 1.270 233 280
2025/20266.538 493 284 738 462 597 465 1.052 335 461 663 380 608
Totale 164.753